Description

Advanced Therapy for Serious Gram-Positive Infections

LINEVESTA INF contains Linezolid, a potent oxazolidinone antibiotic designed to treat life-threatening infections caused by resistant Gram-positive bacteria.

⚡ Powerful & Targeted Action

• Inhibits bacterial protein synthesis at an early stage
• Effective against multi-drug-resistant organisms
• Bacteriostatic with strong clinical outcomes

🦠 Spectrum of Activity

• MRSA (Methicillin-resistant Staphylococcus aureus)
• VRE (Vancomycin-resistant Enterococci)
• Resistant Streptococcal infections

🏥 Indications

• Complicated Skin & Soft Tissue Infections
• Hospital-Acquired Pneumonia (HAP)
• Community-Acquired Pneumonia (CAP)
• Infections caused by resistant Gram-positive pathogens

💡 Why Choose LINEVESTA INF?

• Excellent tissue penetration, including lungs
• Available in ready-to-use infusion (600mg/300ml)
• Ideal for critical care and hospital settings
• Neuro Degenerative Disorders – Early Alzheimer, Parkinson’s, Inefficient Memory
• Ischemic Stroke
• Addicts of Drugs
• Head Trauma & Stroke
• Cognitive Deficits
• Memory Disorder

LINEVESTA INF the special rejuvenator for brain in times of special needs.

Diffuse Threating Infection…